Yun Yen
2023
In 2023, Yun Yen earned a total compensation of $78.1K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 16% decrease compared to previous year.
Compensation breakdown
| Option Awards | $48,131 |
|---|---|
| Other | $30,000 |
| Total | $78,131 |
Yen received $48.1K in option awards, accounting for 62% of the total pay in 2023.
Yen also received $30K in other compensation.
Rankings
In 2023, Yun Yen's compensation ranked 2,927th out of 3,006 executives tracked by ExecPay. In other words, Yen earned more than 2.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,927 out of 3,006 | 3rd |
Division Manufacturing | 1,621 out of 1,650 | 2nd |
Major group Chemicals And Allied Products | 901 out of 918 | 2nd |
Industry group Drugs | 865 out of 881 | 2nd |
Industry Pharmaceutical Preparations | 624 out of 637 | 2nd |
Source: SEC filing on November 4, 2024.
Yen's colleagues
We found four more compensation records of executives who worked with Yun Yen at LIXTE BIOTECHNOLOGY HOLDINGS in 2023.